- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.78 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 1XC: 6-({4-[(3,5-difluorophenyl)sulfonyl]benzyl}carbamoyl)-1-(5-O-phosphono-beta-D-ribofuranosyl)imidazo[1,2-a]pyridin-1-ium(Non-covalent)
- 4 x PO4: PHOSPHATE ION(Non-functional Binders)
PO4.2: 8 residues within 4Å:- Chain A: R.196, E.246, H.247, R.311, D.313
- Chain B: Y.18
- Ligands: 1XC.1, PO4.9
11 PLIP interactions:10 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:H.247, B:Y.18
- Water bridges: A:R.196, A:R.196, A:R.196, A:E.246, A:E.246, A:S.248
- Salt bridges: A:R.196, A:H.247, A:R.311
PO4.9: 8 residues within 4Å:- Chain A: R.196
- Chain B: R.392, S.398, F.399, K.400
- Ligands: 1XC.1, PO4.2, EDO.10
9 PLIP interactions:8 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:F.399, A:R.196
- Water bridges: B:R.392, B:F.399, B:K.400, B:K.415, B:K.415
- Salt bridges: B:R.392, B:K.400
PO4.18: 8 residues within 4Å:- Chain A: Y.18
- Chain B: R.196, E.246, H.247, R.311, D.313
- Ligands: 1XC.17, PO4.25
11 PLIP interactions:10 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:H.247, A:Y.18
- Water bridges: B:R.196, B:R.196, B:R.196, B:E.246, B:E.246, B:S.248
- Salt bridges: B:R.196, B:H.247, B:R.311
PO4.25: 8 residues within 4Å:- Chain A: R.392, S.398, F.399, K.400
- Chain B: R.196
- Ligands: 1XC.17, PO4.18, EDO.26
9 PLIP interactions:8 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:F.399, B:R.196
- Water bridges: A:R.392, A:F.399, A:K.400, A:K.415, A:K.415
- Salt bridges: A:R.392, A:K.400
- 26 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 8 residues within 4Å:- Chain A: H.247, S.248, T.251
- Chain B: K.400, C.401, F.414, K.415, S.425
Ligand excluded by PLIPEDO.4: 7 residues within 4Å:- Chain A: Y.23, K.24, Y.26, P.27, P.28, Y.142
- Chain B: H.264
Ligand excluded by PLIPEDO.5: 6 residues within 4Å:- Chain A: G.122, F.123, V.124, R.434, F.440, N.479
Ligand excluded by PLIPEDO.6: 9 residues within 4Å:- Chain A: D.192, G.194, Y.195, V.198, A.204, G.207, A.208, T.220, L.387
Ligand excluded by PLIPEDO.7: 6 residues within 4Å:- Chain A: S.180, N.182, N.337, S.338, L.343, E.376
Ligand excluded by PLIPEDO.8: 6 residues within 4Å:- Chain A: E.8, F.9, N.10, L.13, A.14
- Chain B: A.222
Ligand excluded by PLIPEDO.10: 5 residues within 4Å:- Chain A: D.313, D.354
- Chain B: K.423
- Ligands: 1XC.1, PO4.9
Ligand excluded by PLIPEDO.11: 6 residues within 4Å:- Chain A: Y.54, N.164, Q.168, D.357, I.358, L.386
Ligand excluded by PLIPEDO.12: 2 residues within 4Å:- Chain A: Y.188
- Ligands: 1XC.1
Ligand excluded by PLIPEDO.13: 6 residues within 4Å:- Chain A: K.53, Y.54, E.55, E.56, E.167, K.170
Ligand excluded by PLIPEDO.14: 4 residues within 4Å:- Chain A: N.67, K.71, K.229, Y.230
Ligand excluded by PLIPEDO.15: 6 residues within 4Å:- Chain A: P.120, F.123, Y.471, E.475, N.479
- Ligands: EDO.16
Ligand excluded by PLIPEDO.16: 4 residues within 4Å:- Chain A: P.120, L.457, H.459
- Ligands: EDO.15
Ligand excluded by PLIPEDO.19: 8 residues within 4Å:- Chain A: K.400, C.401, F.414, K.415, S.425
- Chain B: H.247, S.248, T.251
Ligand excluded by PLIPEDO.20: 7 residues within 4Å:- Chain A: H.264
- Chain B: Y.23, K.24, Y.26, P.27, P.28, Y.142
Ligand excluded by PLIPEDO.21: 6 residues within 4Å:- Chain B: G.122, F.123, V.124, R.434, F.440, N.479
Ligand excluded by PLIPEDO.22: 9 residues within 4Å:- Chain B: D.192, G.194, Y.195, V.198, A.204, G.207, A.208, T.220, L.387
Ligand excluded by PLIPEDO.23: 6 residues within 4Å:- Chain B: S.180, N.182, N.337, S.338, L.343, E.376
Ligand excluded by PLIPEDO.24: 6 residues within 4Å:- Chain A: A.222
- Chain B: E.8, F.9, N.10, L.13, A.14
Ligand excluded by PLIPEDO.26: 5 residues within 4Å:- Chain A: K.423
- Chain B: D.313, D.354
- Ligands: 1XC.17, PO4.25
Ligand excluded by PLIPEDO.27: 6 residues within 4Å:- Chain B: Y.54, N.164, Q.168, D.357, I.358, L.386
Ligand excluded by PLIPEDO.28: 2 residues within 4Å:- Chain B: Y.188
- Ligands: 1XC.17
Ligand excluded by PLIPEDO.29: 6 residues within 4Å:- Chain B: K.53, Y.54, E.55, E.56, E.167, K.170
Ligand excluded by PLIPEDO.30: 4 residues within 4Å:- Chain B: N.67, K.71, K.229, Y.230
Ligand excluded by PLIPEDO.31: 6 residues within 4Å:- Chain B: P.120, F.123, Y.471, E.475, N.479
- Ligands: EDO.32
Ligand excluded by PLIPEDO.32: 4 residues within 4Å:- Chain B: P.120, L.457, H.459
- Ligands: EDO.31
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wang, W. et al., Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitors. Plos One (2014)
- Release Date
- 2014-10-22
- Peptides
- Nicotinamide phosphoribosyltransferase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.78 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 1XC: 6-({4-[(3,5-difluorophenyl)sulfonyl]benzyl}carbamoyl)-1-(5-O-phosphono-beta-D-ribofuranosyl)imidazo[1,2-a]pyridin-1-ium(Non-covalent)
- 4 x PO4: PHOSPHATE ION(Non-functional Binders)
- 26 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wang, W. et al., Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitors. Plos One (2014)
- Release Date
- 2014-10-22
- Peptides
- Nicotinamide phosphoribosyltransferase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A